Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Says 'Open Payments' Data Easier To Use, But Some See Reporting Inefficiencies

This article was originally published in The Gray Sheet

Executive Summary

As CMS releases its 2015 "Open Payments" data on device and drug company payments to physicians, the agency is citing improvements in search tools and usability of the data. But one small startup device firm described onerous and inefficient reporting requirements, and the American Medical Association is citing "registration challenges" and continued data errors on the physician end.

You may also be interested in...



New Sunshine Rules In The EU, And How They Compare To US Requirements

Two EU member states are introducing new sunshine rules to boost transparency. Is the EU following the US lead? Attorneys Hein van den Bos and Ron Wisor discuss EU trends and US burdens.

Grassley Asks Price To Preserve 'Open Payments' Database

Sen. Chuck Grassley, R-Iowa, urged US Department of Health and Human Services secretary nominee Tom Price to preserve the "Open Payments" database that was established by Grassley's Physician Payment Sunshine Act, even if the Affordable Care Act, by which the Sunshine law was enacted, is repealed.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT038362

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel